Interventional Glaucoma

Study demonstrates safety of PLT and its potential to treat open angle glaucoma

Gamma-irradiated cornea allograft is safe and effect for use in glaucoma surgery, according to a paper published in the latest issue of the Journal of Glaucoma.

The International Glaucoma Association (IGA) will be awarding five grants totaling ?255 000 for critical glaucoma research.

Malignant glaucoma can be successfully managed using the stepladder technique, including timely and appropriate interventions, claims a paper in the journal Ophthalmology.

Combined scleral buckle and Baerveldt glaucoma implantation (BGI) is effective for managing coexisting glaucoma and retinal detachment.

According to recently published data, POAG patients with diabetes mellitus (DM) undergoing primary trabeculectomy with MMC do not achieve the same long-term IOP control compared to patients without DM.

A new pressure-sensitive contact lens is tolerable and safe over a 24-hour wearing period for healthy subjects and glaucoma sufferers.

Trabectome, a device that ablates the arc of trabecular meshwork, is a safe and effective alternative to glaucoma surgery, according to a recent paper.

An overview of trials comparing topical medical therapies

SLP has excellent reproducibility and may be useful in monitoring glaucoma progression.

EyeTechCare has secured ?10 million in a third round of funding for two international clinical trials for the EyeOP1 glaucoma treatment.

Tract-based spatial statistical analysis of diffusion tensor imaging is a successful tool for the detection of cortical nerve fibre loss in primary open-angle glaucoma (POAG) patients, claims a recent paper.

Glaucoma and ocular hypertension (OHT) patients are highly satisfied with ocular hypertensives, claims a recent investigation.

Beclomethasone nasal spray doesn't increase IOP in patients with ocular hypertension and primary open-angle glaucoma, reveals a study in the Journal of Glaucoma.

Ivantis announced the completion of financing $27 million for a novel glaucoma procedure at the Glaucoma Research Foundation's latest meeting.

Bausch + Lomb has initiated its phase III clinical program of latanoprostene bunod (licensed by Nicox S.A.) for the reduction of IOP in glaucoma or ocular hypertension.

Patient adherence to glaucoma medication could increase with morning application of glaucoma medication.

Thinner corneas could be linked to higher glaucoma severity.

Severe Fuchs endothelial corneal dystrophy (FECD) increases the risk of developing glaucoma and/or ocular hypertension (G/OHT).

Axial length/refractive status affects the peripapillary retinal nerve fibre layer (RNFL) thickness profile in eyes measured by RTVue OCT.

Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012.

Multiple micro-bypass stents with concurrent cataract surgery lowers IOP to less than 15 mmHg in patients with open-angle glaucoma (OAG) and cataract.

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

Macular scan OCT could be used for the diagnosis and management of glaucoma.

The long-term use of anti-glaucoma eye drops is linked to changes in meibomian gland morphology and function.